Derma Sciences Inc. (DSCI) Swings to Q4 Profit
Derma Sciences Inc. (NASDAQ: DSCI) reports Q4 EPS of $0.01, versus $0.12 reported for the same period a year ago. Revenue for the quarter was $13.65 million, compared to $12.56 million in Q408.
You May Also Be Interested In
- ExxonMobil (XOM) Tops Q3 EPS by 18c
- Independence Realty Trust (IRT) Posts Mixed Q3 Results
- Mast Therapeutics, Inc. (MSTX) Reports In-Line Q3 Loss
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!